$56.53
-0.79 (-1.38%)
Celgene Corp (CELG)
CAPS Rating:
A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.

RSS Headlines
Fool UK
Recs
In light of the approval of Avastin by FDA to Genetech, I believe this company will gets its approvals of its rich pipeline and its stock should go up.